Loading clinical trials...

Study of Preoperative Docetaxel or Cisplatin (CDDP) + Docetaxel for C-stage IB-II Non-Small Cell Lung Cancer (NSCLC) | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 2NCT00132639

Study of Preoperative Docetaxel or Cisplatin (CDDP) + Docetaxel for C-stage IB-II Non-Small Cell Lung Cancer (NSCLC)

The purpose of this study is to evaluate the safety and efficacy of the preoperative docetaxel and docetaxel-cisplatin combination in c-stage IB/II NSCLC, and select the optimal preoperative therapy f...

Lead sponsor: Haruhiko Fukuda•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGNA

Precision Lung Cancer Survivorship Care Intervention

NCT05857995 · Lung Cancer, Pulmonary Neoplasm, and more

Not Yet RecruitingPhase 1/2

Feasibility of Fluorescence Imaging with Bevacizumab-800CW During Bronchoscopy

NCT06809946 · Lung Neoplasms, Pulmonary Neoplasms, and more

COMPLETED

Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer

NCT02410603 · Lung Cancer, Lung Neoplasms, and more

COMPLETEDPhase 2

Study of Arsenic Trioxide in Small Cell Lung Cancer

NCT01470248 · Lung Cancer, Cancer of Lung, and more

COMPLETED

A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System

NCT02370303 · Lung Cancer, Lung Neoplasms, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 22, 2016Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment80

Start dateOct 2002

Last updatedSep 22, 2016

Condition

Pulmonary Neoplasms

Locations shown

National Cancer Center

Chuo-ku,Tsukiji,5-1-1, Tokyo

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 22, 2016Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions